EVerMed, Inc.
PrivateLast Round
Seed
Jan 28, 2025
Total Funding Raised
$2.94M
Company Overview
EVerMed, Inc. is a biotechnology company that develops extracellular vesicle (EV)-based therapeutics for intractable respiratory diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
EVerMed, Inc. Comparables
Compare EVerMed, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| OmniSpirant Therapeutics | 84% | |
| EXORPHIA Inc. | 84% | |
| Evox Therapeutics | 77% | |
EVerMed, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jan 28, 2025 |
EVerMed, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Nissay Capital | Seed |
| WASEDA University Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 28, 2025
$3M round with Nissay Capital and WASEDA University Ventures
EVerMed, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about EVerMed, Inc.'s valuation, stock price, and market status.